Veterinary Drug Bioequivalence Testing Partner

MULTIPLE TESTING & SAMPLES

LONG TERM

BUDGET APPROVED ($50,000-$100,000)

We are developing a suite of generic veterinary drug applications for submission to the FDA-CVM. Our plan is to avoid animal testing by demonstrating bioequivalence via in vitro dissolution testing to USP <711> (apparatus 2)– this is common in veterinary oral pastes and oral suspensions. We have several pilot batches manufactured of at least two different generic formulae. We need a USA laboratory to support our testing and data needs.